Iambic
Click to visit website
About
Iambic is an AI-driven drug discovery platform that integrates advanced physics-based algorithms with a high-throughput automated laboratory. Its primary objective is to solve the most difficult design challenges in drug development, focusing on identifying superior small-molecule medicines for patients with unmet medical needs. By merging computational innovation with real-world experimental execution, the company creates a rapid iteration cycle that converts new molecular concepts into biological data on a weekly basis. This approach significantly compresses the traditional timelines associated with early-stage drug discovery and lead optimization. The core of the platform lies in its physics-based AI technology, which provides a more fundamental understanding of molecular interactions than conventional data-driven machine learning models. This enables Iambic to navigate complex chemical spaces and optimize multiple target product profiles in parallel. The platform is particularly adept at identifying novel mechanisms of action, such as cryptic pockets, allostery, and protein-protein interactions. These capabilities allow the team to transform targets previously considered undruggable into viable opportunities for breakthrough therapeutic interventions. Iambic’s platform is utilized both for internal pipeline development and strategic industry partnerships. Their current therapeutic focus is heavily centered on oncology, with advanced programs like a HER2-selective inhibitor for metastatic disease that features high brain penetrance. Another key program is their CDK2/4 inhibitor, designed to treat cyclin D and E driven cancers while avoiding the off-target toxicities common in traditional treatments. Beyond its internal assets, Iambic collaborates with major pharmaceutical entities like Takeda to apply its AI-driven design capabilities to external discovery challenges. What distinguishes Iambic from other AI biotech firms is the synergy between its world-class scientific advisory board—which includes Nobel Laureates and AI pioneers—and its proprietary laboratory automation. This ensures that the AI predictions are constantly validated and refined by high-quality biological evidence. By placing cutting-edge AI tools directly into the hands of experienced drug hunters, Iambic delivers differentiated clinical candidates at a pace that is years faster than industry standards, effectively bridging the gap between digital innovation and clinical application.
Pros & Cons
Physics-based AI offers deeper molecular insights than standard data-driven models.
High-throughput lab automation provides weekly biological feedback for rapid iteration.
Demonstrated clinical success with programs like HER2 entering Phase 1 studies.
Expert leadership team including Nobel Prize-winning scientific advisors like Frances Arnold.
Proven ability to design brain-penetrant molecules for metastatic disease.
No public-facing software tool is available for independent researcher use.
Specific pricing and partnership terms are not publicly disclosed.
Platform capabilities for non-oncology therapeutic areas are currently less documented.
Use Cases
Pharmaceutical partners can collaborate with Iambic to design small molecules for challenging or undruggable targets.
Oncology researchers can leverage the platform to identify molecules with high selectivity and brain penetrance for metastatic cancers.
Drug hunters can use physics-based AI to discover novel allosteric mechanisms and protein-protein interaction inhibitors.
Platform
Task
Features
• physics-based ai algorithms
• clinical candidate pipeline
• weekly design-to-data cycles
• allosteric pocket identification
• brain-penetrant molecule design
• chemical space exploration
• target product profile optimization
• high-throughput experimental automation
FAQs
What is unique about Iambic's AI approach?
Iambic uses physics-based AI algorithms rather than just pattern recognition from existing datasets. This fundamental approach allows the platform to explore novel chemical spaces and identify unique mechanisms of action, like allosteric pockets, that traditional methods might miss.
How fast does the platform generate biological insights?
The platform is built for high-throughput execution, converting new molecular designs into biological data on a weekly basis. This rapid feedback loop enables the team to iterate and optimize drug candidates at a pace significantly faster than the industry average.
What specific therapeutic areas does Iambic focus on?
While the platform is broadly applicable, current pipeline programs focus on oncology. This includes a Phase 1 HER2 program for metastatic disease and a first-in-class CDK2/4 program designed to address cyclin-driven cancers while reducing off-target toxicities.
Does Iambic collaborate with other pharmaceutical companies?
Yes, Iambic engages in technology and discovery collaborations with industry leaders, such as Takeda. These partnerships leverage Iambic's AI-driven design platform to discover small molecules for specific targets identified by the partner.
Job Opportunities
Head of Translational Oncology
Accelerate drug discovery using physics-based AI and high-throughput automation to design superior medicines and optimize therapeutic profiles for unmet patient needs.
Benefits:
competitive pay
company paid healthcare
flexible spending accounts
voluntary life insurance
401K matching
Education Requirements:
Ph.D., M.D., or equivalent advanced degree in cancer biology, molecular biology, pharmacology, computational biology, or a related discipline.
Experience Requirements:
Typically 12–20+ years of relevant experience in biotech or pharma, with progressive leadership responsibility.
Demonstrated success advancing at least one oncology program into clinical development.
Other Requirements:
Deep expertise in translational science, including biomarker strategy, MoA, resistance, and combination biology.
Proven experience working with large, complex translational and/or clinical datasets.
Strong working knowledge of AI/ML concepts as applied to drug discovery and development.
Excellent scientific storytelling and communication skills.
Responsibilities:
Lead Portfolio-Level Translational Strategy
Define Biomarker & Patient Selection Strategy
Mechanism of Action, Resistance & Combination Biology
AI/ML-Enabled Translational & Clinical Prediction
Build and Lead a High-Impact Organization
Show more details
Research Scientist II / Senior, Translational Biology
Accelerate drug discovery using physics-based AI and high-throughput automation to design superior medicines and optimize therapeutic profiles for unmet patient needs.
Benefits:
competitive pay
company paid healthcare
flexible spending accounts
voluntary life insurance
401K matching
Education Requirements:
PhD in biochemistry, cell biology, cancer biology, pharmacology, or related discipline
MS with 7+ years of experience
BS with 9+ years of experience
Experience Requirements:
2 - 8 years of relevant academic or industry experience (PhD)
Experience in cancer research, mechanism of action/resistance, or translational biomarker development
Hands-on experience in in vivo pharmacology
Other Requirements:
Strong proficiency in cell and molecular biology
Experience developing and troubleshooting biochemical and cell-based assays
Excellent communication skills
Responsibilities:
Work closely with Biology group to design translational studies
Design and manage in vivo pharmacology studies at CROs
Design and execute hands-on experiments in cell and molecular biology
Analyze and interpret data from internal experiments and CRO deliverables
Conduct literature reviews to support biomarker strategies
Show more details
Sr Associate Scientist I or II, Medicinal Chemistry
Accelerate drug discovery using physics-based AI and high-throughput automation to design superior medicines and optimize therapeutic profiles for unmet patient needs.
Benefits:
competitive pay
company paid healthcare
flexible spending accounts
voluntary life insurance
401K matching
Education Requirements:
BS in Chemistry
MS in Chemistry
Experience Requirements:
5+ years experience (pharma/biotech) for BS
3+ years experience (pharma/biotech) for MS
5+ years of experience contributing to drug discovery projects
Other Requirements:
Proven skills in multi-step organic synthesis
Reaction optimization and SAR analysis skills
Ability to thrive in a fast-paced environment
Familiarity with ADME-PK principles
Responsibilities:
Design, synthesize, purify, and characterize chemical compounds
Identify and optimize reaction conditions
Collaborate with the high-throughput experimentation team
Analyze biological and ADME-PK data
Partner with computational chemists
Show more details
Ratings & Reviews
No ratings available yet. Be the first to rate this tool!
Alternatives
X-Chem
Identify high-quality drug leads and optimize clinical candidates using DNA-encoded library data and Chemomics to reduce risk in biotech and pharma discovery.
View Details
BenevolentAI
Uncover new therapeutic insights and accelerate drug discovery with AI-driven life science intelligence designed for researchers and pharmaceutical teams.
View Details
Aitia Bio
Aitia Bio uses AI, multi-omic data, and Gemini Digital Twins to accelerate drug discovery and development, focusing on oncology and neurodegenerative diseases.
View Details
Aganitha AI
Aganitha AI is an in silico company that partners with biopharma, personal & homecare, and material sciences industries, leveraging AI to accelerate scientific R&D.
View Details
MindRank
Accelerate small molecule drug discovery and tackle hard-to-drug targets using a clinical-stage AI platform designed for biotech and pharmaceutical researchers.
View Details
Delta4
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
View Details
ALS.ai
Accelerate ALS drug discovery and target identification using deep generative models and multi-omics data analysis to find novel therapeutics for patients.
View Details
canSAR.ai
canSAR.ai is an integrated knowledge-base leveraging machine learning and AI for cancer drug discovery and translational research worldwide.
View Details
Phenomic AI
Identify novel therapeutic targets for hard-to-treat solid tumors by using an ML-powered transcriptomics platform to analyze single-cell RNA and stromal biology.
View Details
biotx.ai
Help pharmaceutical researchers accelerate drug discovery and minimize clinical trial failure by mapping causal genetic links using AI-driven Mendelian randomization.
View Details
Proxima
Design programmable protein interactions and discover next-generation proximity-based medicines using an integrated AI platform for biopharmaceutical research.
View Details
Iktos
Accelerate drug discovery by integrating generative AI with automated robotics to design, synthesize, and test novel molecules in under two years for pharma teams.
View Details
Atomic AI
Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.
View Details
Iambic
Design superior therapeutic molecules and accelerate drug discovery using physics-based AI algorithms and high-throughput experimental feedback loops.
View Details
GSK.ai
Accelerate drug discovery and vaccine development by leveraging AI to interpret complex genetic datasets and understand the fundamental language of human cells.
View Details
Cognit
Accelerate functional genomics research and simulate complex gene regulatory networks using cross-species foundational AI models for in-silico cell engineering.
View Details
Gero
Extend healthy human lifespan and discover novel therapeutic targets using physics-informed AI models trained on over 100 million longitudinal medical records.
View Details
Receptor.AI
Optimize early-stage drug discovery for biotech researchers using an AI ecosystem that identifies cryptic binding sites and predicts over 80 ADMET endpoints.
View Details
Wisecube
Accelerate life sciences R&D using a foundational graph AI that unifies billions of biomedical data points to provide reliable, literature-backed insights.
View DetailsFeatured Tools
adly.news
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
View Details
AI Fruit
Create viral fruit-eating-fruit ASMR videos for TikTok and YouTube in seconds using advanced AI models like Grok and Kling without any video editing skills.
View Details
DramaPixel
Streamline your creative workflow by generating professional images, videos, and music in one unified AI workspace designed for marketers and brand designers.
View Details
Frondex
Accelerate investment research and strategy with an AI copilot that provides deep industry dives, market trend analysis, and seamless tool integrations for investors.
View Details
Atomic Mail
Protect your data with end-to-end encryption and an AI suite that drafts, summarizes, and scans emails for sensitive content to ensure maximum privacy.
View Details
Rekap
Turn every meeting, call, and document into actionable takeaways with AI-powered transcription and custom automation tools designed for fast-moving teams.
View Details
Sketch To
Convert images into artistic sketches or transform hand-drawn drafts into realistic photos using advanced AI models designed for artists, designers, and hobbyists.
View Details
Seedance 4.0
Create high-definition AI videos from text prompts or images in seconds with built-in audio, commercial rights, and support for multiple cinematic models.
View Details